AP Biosciences Statistics

Total Valuation

AP Biosciences has a market cap or net worth of TWD 10.64 billion. The enterprise value is 9.34 billion.

Market Cap	10.64B
Enterprise Value	9.34B

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

AP Biosciences has 85.11 million shares outstanding. The number of shares has increased by 16.28% in one year.

Current Share Class	85.11M
Shares Outstanding	85.11M
Shares Change (YoY)	+16.28%
Shares Change (QoQ)	+29.58%
Owned by Insiders (%)	5.90%
Owned by Institutions (%)	13.02%
Float	45.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	7.28
P/TBV Ratio	7.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-23.70
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.16

Financial Position

The company has a current ratio of 49.57, with a Debt / Equity ratio of 0.04.

Current Ratio	49.57
Quick Ratio	48.19
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.19
Interest Coverage	-263.05

Financial Efficiency

Return on equity (ROE) is -24.27% and return on invested capital (ROIC) is -14.91%.

Return on Equity (ROE)	-24.27%
Return on Assets (ROA)	-14.70%
Return on Invested Capital (ROIC)	-14.91%
Return on Capital Employed (ROCE)	-26.60%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +115.77% in the last 52 weeks. The beta is 0.74, so AP Biosciences's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+115.77%
50-Day Moving Average	72.98
200-Day Moving Average	56.92
Relative Strength Index (RSI)	63.71
Average Volume (20 Days)	1,012,956

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-404.31M
Pretax Income	-394.19M
Net Income	-394.19M
EBITDA	-395.47M
EBIT	-404.31M
Earnings Per Share (EPS)	-4.63

Full Income Statement

Balance Sheet

The company has 1.36 billion in cash and 65.24 million in debt, giving a net cash position of 1.30 billion or 15.23 per share.

Cash & Cash Equivalents	1.36B
Total Debt	65.24M
Net Cash	1.30B
Net Cash Per Share	15.23
Equity (Book Value)	1.46B
Book Value Per Share	17.14
Working Capital	1.38B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -326.47 million and capital expenditures -17.55 million, giving a free cash flow of -344.02 million.

Operating Cash Flow	-326.47M
Capital Expenditures	-17.55M
Free Cash Flow	-344.02M
FCF Per Share	-4.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AP Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.28%
Shareholder Yield	n/a
Earnings Yield	-3.71%
FCF Yield	-3.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2